Biomerica (BMRA) Equity Average (2011 - 2026)

Biomerica has disclosed Equity Average across 16 years of filings, most recently posting $3.9 million for Q1 2026.

• Equity Average for Q1 2026 came in at $3.9 million, down 27.2% year-over-year; the trailing twelve-month figure through Feb 2026 was $3.9 million (down 27.2% YoY), and the FY2025 annual result was $5.3 million, down 41.6% from the prior year.
• Equity Average came in at $3.9 million for Q1 2026 at Biomerica, down from $4.8 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $11.2 million in Q3 2023 to a low of $3.9 million in Q1 2026.
• The 5-year median for Equity Average is $7.2 million (2024), against an average of $7.2 million.
• Across the five-year window, Equity Average jumped 35.11% in 2023 and slumped 48.09% in 2024, its largest moves.
• Biomerica's Equity Average stood at $7.8 million in 2022, then increased by 29.46% to $10.1 million in 2023, then plunged by 48.09% to $5.2 million in 2024, then retreated by 8.32% to $4.8 million in 2025, then fell by 19.17% to $3.9 million in 2026.
• The last three Equity Average figures came in at $3.9 million (Q1 2026), $4.8 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.